Long-term outcome of coronary artery bypass grafting in patients with left ventricular dysfunction

Paolo Nardi1, Antonio Pellegrino, Antonio Scafuri

  • 1Department of Cardiac Surgery, Policlinico Tor Vergata, Tor Vergata University of Rome, Rome, Italy. pa.nardi@hotmail.it

Insights

Coronary artery bypass grafting (CABG) offers excellent long-term outcomes for patients with coronary artery disease and reduced left ventricular ejection fraction (LVEF). Achieving complete revascularization is key to improving survival and reducing myocardial infarction rates.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Heart Failure Management

Background:

  • Coronary artery bypass grafting (CABG) is a standard treatment for multivessel coronary artery disease with left ventricular dysfunction.
  • Evaluating long-term results in patients with a preoperative left ventricular ejection fraction (LVEF) of 0.35 or less is crucial.

Purpose of the Study:

  • To assess the long-term efficacy and survival rates following CABG in patients with severely impaired left ventricular function (LVEF ≤ 0.35).
  • To identify predictors of operative mortality and late adverse cardiac events in this high-risk patient cohort.

Main Methods:

  • Analysis of data from 302 consecutive patients undergoing CABG with LVEF ≤ 0.35.
  • Use of inotropic agents (epinephrine, enoximone) and vasopressors (norepinephrine) to support cardiac index.
  • Application of mechanical circulatory support (intra-aortic balloon pump, left ventricular assist devices) for postoperative low output syndrome.

Main Results:

  • Complete revascularization (98.7%) and use of internal thoracic artery (97.4%) were high.
  • Operative mortality was 5.3%, predicted by emergency CABG, ventricular arrhythmias, and prior anterior myocardial infarction.
  • Ten-year survival was 63%, with predictors of late mortality including ventricular arrhythmias, renal dysfunction, and diabetes.
  • Significant LVEF improvement was observed post-CABG (0.43 vs. 0.28).
  • Ten-year freedom from myocardial infarction was 87%.

Conclusions:

  • CABG provides excellent long-term results for patients with LVEF ≤ 0.35.
  • Complete revascularization and internal thoracic artery grafting are associated with reduced myocardial infarction.
  • Management of arrhythmias, diabetes, and renal dysfunction is vital for improving long-term survival.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...